{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:27:28Z","timestamp":1792477648544,"version":"4.5.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001703","name":"\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nbd.2020.104876","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T21:13:28Z","timestamp":1587762808000},"page":"104876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports"],"prefix":"10.1016","volume":"141","author":[{"given":"Hilal A.","family":"Lashuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.nbd.2020.104876_bb0010","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0015","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2020.01.027","article-title":"Posttranslational modifications mediate the structural diversity of tauopathy strains","volume":"180","author":"Arakhamia","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0020","doi-asserted-by":"crossref","first-page":"17625","DOI":"10.1038\/srep17625","article-title":"Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson\u2019s disease patients","volume":"5","author":"Araki","year":"2015","journal-title":"Sci. Rep."},{"issue":"36","key":"10.1016\/j.nbd.2020.104876_bb0025","doi-asserted-by":"crossref","first-page":"17963","DOI":"10.1073\/pnas.1906124116","article-title":"Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of alpha-synuclein","volume":"116","author":"Araki","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0006-8993(98)00734-3","article-title":"Immunoelectron-microscopic demonstration of NACP\/\u03b1-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies","volume":"808","author":"Arima","year":"1998","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0035","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3940(99)00311-0","article-title":"\u03b1-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease \u03b2-amyloid plaque cores","volume":"266","author":"Bayer","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"9440","key":"10.1016\/j.nbd.2020.104876_bb0045","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.nbd.2020.104876_bb0050","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0060","doi-asserted-by":"crossref","first-page":"e9313","DOI":"10.1371\/journal.pone.0009313","article-title":"Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy","volume":"5","author":"Crews","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-5793(98)01146-6","article-title":"Synthetic filaments assembled from C-terminally truncated alpha-synuclein","volume":"436","author":"Crowther","year":"1998","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0304-3940(00)01440-3","article-title":"Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain","volume":"292","author":"Crowther","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF00310030","article-title":"Relationships between Lewy bodies and pale bodies in Parkinson's disease","volume":"83","author":"Dale","year":"1992","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.nbd.2020.104876_bb0080","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1093\/brain\/awz329","article-title":"Intrastriatal injection of alpha-synuclein fibrils induces Parkinson-like pathology in macaques","volume":"142","author":"Dehay","year":"2019","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0085","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/jnc.14806","article-title":"Cellular models of alpha-synuclein toxicity and aggregation","volume":"150","author":"Delenclos","year":"2019","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40478-019-0733-3","article-title":"Comparative analyses of the in vivo induction and transmission of alpha-synuclein pathology in transgenic mice by MSA brain lysate and recombinant alpha-synuclein fibrils","volume":"7","author":"Dhillon","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.nbd.2020.104876_bb0095","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.41.9.1402","article-title":"Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD","volume":"41","author":"Dickson","year":"1991","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0100","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005072-196507000-00003","article-title":"Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus caeruleus in Parkinson's disease*\u2020","volume":"24","author":"Duffy","year":"1965","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0105","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2353\/ajpath.2007.061232","article-title":"Calpain-cleavage of alpha-synuclein: connecting proteolytic processing to disease-linked aggregation","volume":"170","author":"Dufty","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s004010051025","article-title":"Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient","volume":"97","author":"van Duinen","year":"1999","journal-title":"Acta Neuropathol."},{"issue":"1-2","key":"10.1016\/j.nbd.2020.104876_bb0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-5793(98)01419-7","article-title":"Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/13506129.2013.835726","article-title":"Off-pathway alpha-synuclein oligomers seem to alter alpha-synuclein turnover in a cell model but lack seeding capability in vivo","volume":"20","author":"Fagerqvist","year":"2013","journal-title":"Amyloid"},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-018-1914-z","article-title":"Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold","volume":"136","author":"Falcon","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2020.104876_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson's disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"issue":"17","key":"10.1016\/j.nbd.2020.104876_bb0135","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","article-title":"The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of \u03b1-synuclein, and enhances its secretion and nuclear localization in cells","volume":"23","author":"Fares","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2020.104876_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2019.05.002","article-title":"Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification","volume":"129","author":"Fenyi","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"7662","key":"10.1016\/j.nbd.2020.104876_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer's disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1532-5415.1969.tb01316.x","article-title":"Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism","volume":"17","author":"Forno","year":"1969","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJM198601093140218","article-title":"Lewy bodies","volume":"314","author":"Forno","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2020.104876_bb0160","first-page":"35","article-title":"The Lewy body in Parkinson's disease","volume":"45","author":"Forno","year":"1987","journal-title":"Adv. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00688674","article-title":"Ultrastructure of Lewy bodies in the stellate ganglion","volume":"34","author":"Forno","year":"1976","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.nbd.2020.104876_bb0175","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/archneur.1978.00500360042008","article-title":"Presenile dementia with lewy bodies and neurofibrillary tangles","volume":"35","author":"Forno","year":"1978","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2020.104876_bb0180","first-page":"217","article-title":"Electron microscopy of Lewy bodies in the amygdala-parahippocampal region. Comparison with inclusion bodies in the MPTP-treated squirrel monkey","volume":"69","author":"Forno","year":"1996","journal-title":"Adv. Neurol."},{"issue":"24","key":"10.1016\/j.nbd.2020.104876_bb0185","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1021\/bi7000246","article-title":"The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states","volume":"46","author":"Fredenburg","year":"2007","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0195","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/exnr.2000.7527","article-title":"In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies","volume":"166","author":"Gai","year":"2000","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0200","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00005072-198811000-00008","article-title":"Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles","volume":"47","author":"Galloway","year":"1988","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0205","first-page":"809","article-title":"Filaments of Lewy bodies contain insoluble cytoskeletal elements","volume":"140","author":"Galloway","year":"1992","journal-title":"Am. J. Pathol."},{"issue":"40","key":"10.1016\/j.nbd.2020.104876_bb0210","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1021\/bi400999d","article-title":"The Parkinson\u2019s disease-associated H50Q mutation accelerates \u03b1-synuclein aggregation in vitro","volume":"52","author":"Ghosh","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2020.104876_bb0215","article-title":"Molecular structure of a prevalent amyloid-\u03b2 fibril polymorph from Alzheimer\u2019s disease brain tissue","author":"Ghosh","year":"2020","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870060103","article-title":"Neuronal inclusions of Parkinson's disease","volume":"6","author":"Gibb","year":"1991","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104876_bb0225","series-title":"Basic Neurochemistry","first-page":"829","article-title":"Chapter 47 - Synucleinopathies and tauopathies","author":"Goedert","year":"2012"},{"issue":"s1","key":"10.1016\/j.nbd.2020.104876_bb0230","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3233\/JPD-179005","article-title":"The synucleinopathies: twenty years on","volume":"7","author":"Goedert","year":"2017","journal-title":"J. Parkinsons Dis."},{"issue":"4615","key":"10.1016\/j.nbd.2020.104876_bb0235","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1126\/science.6308771","article-title":"Lewy bodies of Parkinson's disease contain neurofilament antigens","volume":"221","author":"Goldman","year":"1983","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0240","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s004010051135","article-title":"alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining","volume":"99","author":"Gomez-Tortosa","year":"2000","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.nbd.2020.104876_bb0245","doi-asserted-by":"crossref","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","article-title":"Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease","volume":"115","author":"Grassi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.nbd.2020.104876_bb0250","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in alpha-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","article-title":"Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC","volume":"6","author":"Groveman","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0260","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/19336896.2020.1724608","article-title":"RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy","volume":"14","author":"Han","year":"2020","journal-title":"Prion"},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0265","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00334457","article-title":"An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism","volume":"85","author":"Hayashida","year":"1993","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0270","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00334457","article-title":"An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism","volume":"85","author":"Hayashida","year":"1993","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0275","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/cne.903090111","article-title":"Epitopes located in spatially separate domains of each neurofilament subunit are present in parkinson's disease Lewy bodies","volume":"309","author":"Hill","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2020.104876_bb0280","series-title":"Shock Discovery From Parkinson's Research","author":"https:\/\/analyticalscience.wiley.com\/","year":"2019"},{"key":"10.1016\/j.nbd.2020.104876_bb0285","series-title":"Forget Fibrils: Lewy Pathology Is More Lipid Than Protein","author":"https:\/\/www.alzforum.org","year":"2019"},{"key":"10.1016\/j.nbd.2020.104876_bb0290","series-title":"Parkinsonian Lewy Bodies Are Not What We Thought","author":"https:\/\/www.biocompare.com\/","year":"2019"},{"key":"10.1016\/j.nbd.2020.104876_bb0295","series-title":"Is It Time to Rethink Parkinson\u2019s Pathology?","author":"https:\/\/www.the-scientist.com\/","year":"2019"},{"key":"10.1016\/j.nbd.2020.104876_bb0300","series-title":"New Contents: Neuronal Parkinson Inclusions Are Different Than Expected","author":"https:\/\/www.unibas.ch\/","year":"2019"},{"issue":"9440","key":"10.1016\/j.nbd.2020.104876_bb0305","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease","volume":"364","author":"Ibanez","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0310","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00005072-199804000-00005","article-title":"Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity","volume":"57","author":"Irizarry","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0315","first-page":"1517","article-title":"Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease","volume":"148","author":"Iwatsubo","year":"1996","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0320","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneur.1969.00480180071006","article-title":"Sphingomyelin in Lewy inclusion bodies in Parkinson's disease","volume":"21","author":"den Jager","year":"1969","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0325","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Med."},{"issue":"41","key":"10.1016\/j.nbd.2020.104876_bb0330","doi-asserted-by":"crossref","first-page":"26292","DOI":"10.1074\/jbc.273.41.26292","article-title":"Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation","volume":"273","author":"Jensen","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0335","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0002-9440(10)63072-6","article-title":"Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model","volume":"159","author":"Kahle","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0340","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1750-3639.2008.00140.x","article-title":"Three-layered structure shared between Lewy bodies and lewy neurites-three-dimensional reconstruction of triple-labeled sections","volume":"18","author":"Kanazawa","year":"2008","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0345","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.27646","article-title":"Comparative study of cerebrospinal fluid alpha-synuclein seeding aggregation assays for diagnosis of Parkinson's disease","volume":"34","author":"Kang","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2020.104876_bb0350","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/srep05797","article-title":"Quantitative measurement of intact alpha-synuclein proteoforms from post-mortem control and Parkinson's disease brain tissue by intact protein mass spectrometry","volume":"4","author":"Kellie","year":"2014","journal-title":"Sci. Rep."},{"issue":"32","key":"10.1016\/j.nbd.2020.104876_bb0355","doi-asserted-by":"crossref","first-page":"21856","DOI":"10.1074\/jbc.M114.553297","article-title":"The H50Q mutation enhances \u03b1-synuclein aggregation, secretion, and toxicity","volume":"289","author":"Khalaf","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0360","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/neup.12597","article-title":"Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases","volume":"40","author":"Kon","year":"2020","journal-title":"Neuropathology"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2020.104876_bb0365","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","article-title":"Autosomal dominant Parkinson's disease caused by SNCA duplications","volume":"22","author":"Konno","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0370","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.nbd.2020.104876_bb0375","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","article-title":"Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62","volume":"62","author":"Kuusisto","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2020.104876_bb0380","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00687787","article-title":"Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study","volume":"75","author":"Kuzuhara","year":"1988","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0385","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005072-196707000-00001","article-title":"A comparative electron microscopic study of reactive, degenerating, regenerating, and dystrophic axons","volume":"26","author":"Lampert","year":"1967","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0390","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ana.410030207","article-title":"The hypothalamus in Parkinson disease","volume":"3","author":"Langston","year":"1978","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0395","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1006\/exnr.1998.6975","article-title":"Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease","volume":"154","author":"Langston","year":"1998","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0400","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0022-2836(02)00735-0","article-title":"Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils","volume":"322","author":"Lashuel","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0405","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of alpha-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0410","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s40478-016-0402-8","article-title":"The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation","volume":"4","author":"L\u00e1zaro","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0415","doi-asserted-by":"crossref","first-page":"e49750","DOI":"10.1371\/journal.pone.0049750","article-title":"Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K","volume":"8","author":"Lemkau","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0420","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp.52.1.67","article-title":"Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease","volume":"52","author":"Lennox","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2020.104876_bb0425","series-title":"Paralysis Agitans. I. Pathologische Anatomie","author":"Lewy","year":"1912"},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0430","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"47","key":"10.1016\/j.nbd.2020.104876_bb0435","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6109","key":"10.1016\/j.nbd.2020.104876_bb0440","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.104876_bb0445","article-title":"The making of a Lewy body: the role of \u03b1-synuclein post-fibrillization modifications in regulating the formation and the maturation of pathological inclusions","author":"Mahul-Mellier","year":"2018","journal-title":"bioRxiv"},{"issue":"9","key":"10.1016\/j.nbd.2020.104876_bb0455","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.nbd.2020.104876_bb0460","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1073\/pnas.85.12.4501","article-title":"Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases","volume":"85","author":"Manetto","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0465","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11481-019-09835-4","article-title":"Ultrasensitive detection of aggregated alpha-synuclein in glial cells, human cerebrospinal fluid, and brain tissue using the RT-QuIC assay: new high-throughput neuroimmune biomarker assay for parkinsonian disorders","volume":"14","author":"Manne","year":"2019","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0470","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.mp.4000446","article-title":"Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease","volume":"3","author":"Mezey","year":"1998","journal-title":"Mol. Psychiatry"},{"issue":"35","key":"10.1016\/j.nbd.2020.104876_bb0475","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1021\/acs.biochem.8b00314","article-title":"Comparison of kinetics, toxicity, oligomer formation, and membrane binding capacity of alpha-synuclein familial mutations at the A53 site, including the newly discovered A53V mutation","volume":"57","author":"Mohite","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2020.104876_bb0480","first-page":"470476","article-title":"Detailed structural orchestration of Lewy pathology in Parkinson\u2019s disease as revealed by 3D multicolor STED microscopy","author":"Moors","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2020.104876_bb0485","first-page":"470476","article-title":"Subcellular orchestration of alpha-synuclein variants in Parkinson\u2019s disease brains revealed by 3D multicolor STED microscopy","author":"Moors","year":"2019","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0490","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ana.410430612","article-title":"Hereditary form of parkinsonism\u2014dementia","volume":"43","author":"Muenter","year":"1998","journal-title":"Ann. Neurol."},{"issue":"14","key":"10.1016\/j.nbd.2020.104876_bb0495","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.nbd.2020.104876_bb0500","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1474-4422(04)00827-0","article-title":"Lewy-body formation is an aggresome-related process: a hypothesis","volume":"3","author":"Olanow","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2020.104876_bb0505","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0079-6123(10)83007-9","article-title":"Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies","volume":"183","author":"Oueslati","year":"2010","journal-title":"Prog. Brain Res."},{"issue":"7706","key":"10.1016\/j.nbd.2020.104876_bb0510","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-018-0104-4","article-title":"Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies","volume":"557","author":"Peng","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.104876_bb0515","doi-asserted-by":"crossref","first-page":"24526","DOI":"10.1038\/srep24526","article-title":"Structural and functional properties of prefibrillar alpha-synuclein oligomers","volume":"6","author":"Pieri","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0520","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/j.1471-4159.1992.tb10074.x","article-title":"Detergent-Insoluble Cortical Lewy Body Fibrils Share Epitopes with Neurofilament and \u03c4","volume":"58","author":"Pollanen","year":"1992","journal-title":"J. Neurochem."},{"issue":"5290","key":"10.1016\/j.nbd.2020.104876_bb0525","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1126\/science.274.5290.1197","article-title":"Mapping of a gene for Parkinson's disease to chromosome 4q21-q23","volume":"274","author":"Polymeropoulos","year":"1996","journal-title":"Science"},{"issue":"5321","key":"10.1016\/j.nbd.2020.104876_bb0530","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0535","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1750-3639.2012.00597.x","article-title":"Critical role of truncated alpha-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease","volume":"22","author":"Prasad","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2020.104876_bb0540","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neulet.2015.04.022","article-title":"The A53E alpha-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture","volume":"597","author":"Rutherford","year":"2015","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.nbd.2020.104876_bb0545","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/jnc.12806","article-title":"Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of \u03b1-synuclein","volume":"131","author":"Rutherford","year":"2014","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0550","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/exnr.2002.7961","article-title":"Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red","volume":"177","author":"Sakamoto","year":"2002","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0555","first-page":"53","article-title":"Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies","volume":"139","author":"Schmidt","year":"1991","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0560","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2020.104876_bb0565","article-title":"Structures of \u03b1-synuclein filaments from multiple system atrophy","author":"Schweighauser","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.nbd.2020.104876_bb0570","first-page":"137976","article-title":"Lewy pathology in Parkinson\u2019s disease consists of a crowded organellar membranous medley","author":"Shahmoradian","year":"2017","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.nbd.2020.104876_bb0575","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0580","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","article-title":"Development of a biochemical diagnosis of parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid","volume":"74","author":"Shahnawaz","year":"2017","journal-title":"JAMA Neurol."},{"issue":"7794","key":"10.1016\/j.nbd.2020.104876_bb0585","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating alpha-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0590","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40478-017-0413-0","article-title":"Propagation of pathological alpha-synuclein in marmoset brain","volume":"5","author":"Shimozawa","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"5646","key":"10.1016\/j.nbd.2020.104876_bb0595","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2020.104876_bb0600","series-title":"Dementia in Parkinson's disease","first-page":"187","article-title":"Is a Lewy body always a Lewy body?","author":"Smith","year":"1995"},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0605","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1091\/mbc.e07-08-0827","article-title":"Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae","volume":"19","author":"Soper","year":"2008","journal-title":"Mol. Biol. Cell"},{"issue":"11","key":"10.1016\/j.nbd.2020.104876_bb0610","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"M.G., et al., alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6645","key":"10.1016\/j.nbd.2020.104876_bb0615","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0620","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0625","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","article-title":"Structural heterogeneity of \u03b1-synuclein fibrils amplified from patient brain extracts","volume":"10","author":"Stroh\u00e4ker","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0630","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1440-1789.1994.tb00242.x","article-title":"Ultrastructural relationship between Lewy bodies and pale bodies studied in locus ceruleus neurons of a non-Parkinsonian patient","volume":"14","author":"Takahashi","year":"1994","journal-title":"Neuropathology"},{"key":"10.1016\/j.nbd.2020.104876_bb0635","series-title":"Contribution a l'etude de l'Anatomie pathologique du Locus Niger de Soemmering avec quelques deduction relatives a la pathogenie des troubles du tonus musculaire et de la maladie de Parkinson","author":"Tretiakoff","year":"1919"},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0640","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archneur.55.2.151","article-title":"Aggregation of neurofilament and \u03b1-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia","volume":"55","author":"Trojanowski","year":"1998","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0645","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2353\/ajpath.2006.050770","article-title":"Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies","volume":"168","author":"Uryu","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"11","key":"10.1016\/j.nbd.2020.104876_bb0650","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","article-title":"alpha-Synuclein-based animal models of Parkinson's disease: challenges and opportunities in a new era","volume":"39","author":"Visanji","year":"2016","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0655","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.nbd.2020.104876_bb0660","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00687767","article-title":"Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses","volume":"76","author":"Wakabayashi","year":"1988","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.nbd.2020.104876_bb0665","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s004010050918","article-title":"Accumulation of alpha-synuclein\/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy","volume":"96","author":"Wakabayashi","year":"1998","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.nbd.2020.104876_bb0670","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40478-019-0696-4","article-title":"Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration","volume":"7","author":"Wang","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.nbd.2020.104876_bb0675","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00703325","article-title":"Dense core vesicles around the Lewy body in incidental Parkinson's disease: an electron microscopic study","volume":"39","author":"Watanabe","year":"1977","journal-title":"Acta Neuropathol."},{"issue":"48","key":"10.1016\/j.nbd.2020.104876_bb0680","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2020.104876_bb0685","first-page":"8","article-title":"Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer's and Pick's diseases","author":"Zhang","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.nbd.2020.104876_bb0690","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","article-title":"Novel tau filament fold in corticobasal degeneration","volume":"580","author":"Zhang","year":"2020","journal-title":"Nature"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120301510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120301510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:20:21Z","timestamp":1760851221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120301510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":136,"alternative-id":["S0969996120301510"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104876","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.104876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104876"}}